FGL

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameFGL
Drug Alias NameNCAM mimetics (Enkam)NeuroFGLFGLFGLL
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFibroblast growth factor receptors modulatorsBeta amyloid A4 protein modulatorsCNS modulators
TargetsFibroblast growth factor receptorsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer DiseaseStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnkam Pharmaceuticals A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnkam Pharmaceuticals A/S
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseStroke

Other Information

ATC CodeN/A
Related LinksN/A